SecBot SecBot
Insider Buy ·Filed Sep 15, 2026

CARL

CARLSMED, INC.
BULLISH
Impact 6/10
Horizonweeks Processed1mo ago SEC0001193125-26-392111
Insider cluster: 1 insiders, $3.0M total
Actionable Insight ▲ Bullish

This is a strong bullish signal from a 10% owner deploying significant capital. Traders should monitor for potential positive catalysts such as upcoming earnings, product approvals, or strategic announcements that may have prompted this insider's conviction. The size relative to market cap warrants attention.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
CARL ▼ -5.49% at T+20d
LONG call ✗ call lost -5.49% · α vs SPY -8.66% · entry $15.31 → $14.47
Next anchor: T+60d in 6w
Latest observation: T+27 -16.64% FF3 residual α
Entry = T+0 close
Sep 15, 2026
via day close
T+1d
+0.52%
call +0.52% · α -0.61%
$15.39
settled 6w ago
T+5d
-3.59%
call -3.59% · α -6.16%
$14.76
settled 5w ago
T+20d
-5.49%
call -5.49% · α -8.66%
$14.47
settled 14d ago
T+60d
Pending
in 6w

Price Chart

Loading chart...

Executive Summary

A 10% owner of Carlsmed, Presidio Management Group XII, L.L.C., made a single open-market purchase of 200,000 shares for $3.0 million at $15.00 per share on July 24, 2025. This is a large, conviction buy from a major shareholder, representing approximately 0.72% of the company's $419M market cap, which is a significant insider signal.

Key Financial Metrics

Direction
buying
Total Value
$3.0M
Insiders
1

Key Facts

  • 10% owner Presidio Management Group XII, L.L.C. purchased 200,000 shares at $15.00/share.
  • Total purchase value is $3.0 million.
  • The purchase represents approximately 0.72% of Carlsmed's $419 million market cap.
  • The transaction occurred on July 24, 2025.
  • This is a single, open-market purchase (code P) by a major shareholder, not a 10b5-1 plan.

Financial Impact

A $3.0 million open-market purchase by a 10% owner, representing 0.72% of market cap.

insider ownership

Risk Factors

  • The purchase could be a prelude to a larger strategic move (e.g., going-private bid) that may not benefit all shareholders equally.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001193125-26-392111
6 reports for CARL
Performance horizon
Filters
Rows
Reports for CARL — sortable, filterable
TypeNow
Oct 14, 2026
13d ago
144
NEUTRAL ★ 2/10
$13.85awaiting T+20—$15.42 (+11.34%)
Sep 30, 2026
27d ago
8-K
NEUTRAL ★ 4/10
$14.07awaiting T+20—$15.42 (+9.59%)
Sep 28, 2026
29d ago
Press Release
NEUTRAL ★ 4/10
$14.18 $14.91▲ +5.15%▲ +5.18%$15.42 (+8.74%)
Sep 15, 2026
6w ago
Insider Buy
BULLISH ★ 6/10
$15.31 $14.47▼ −5.49%▼ −8.66%$15.42 (+0.72%)
Aug 24, 2026
9w ago
EFFECT
NEUTRAL ★ 3/10
$15.80 $15.42▼ −2.41%▼ −3.72%$15.42 (−2.41%)
Jul 22, 2026
13w ago
Press Release
NEUTRAL ★ 1/10
$11.00 $16.50▲ +50.00%▲ +46.69%$15.42 (+40.18%)
Showing 6 of 6

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 15, 2026